Deksametasooni

Deksametasooni is a synthetic glucocorticoid, a type of corticosteroid medication. It is widely used for its potent anti-inflammatory and immunosuppressive properties. Chemically, it is a derivative of prednisolone.

Deksametasooni works by mimicking the action of natural hormones produced by the adrenal glands. It reduces the body's inflammatory response by inhibiting the production of various inflammatory mediators. It also suppresses the immune system, which can be beneficial in treating conditions where the immune system is overactive or attacking the body's own tissues.

This medication is prescribed for a broad range of medical conditions. These include severe allergies, asthma, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, lupus, and other autoimmune diseases. It is also used to treat certain types of cancer, such as leukemia and lymphoma, often to reduce swelling and inflammation caused by tumors or as part of chemotherapy regimens. Deksametasooni can be administered orally, intravenously, intramuscularly, or topically, depending on the condition being treated.

While effective, deksametasooni can have side effects, especially with long-term or high-dose use. Common side effects may include mood changes, increased appetite, weight gain, insomnia, and increased susceptibility to infections. More serious side effects can involve osteoporosis, diabetes, high blood pressure, and adrenal suppression. The dosage and duration of treatment are carefully managed by healthcare professionals to minimize risks.